Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P2.11-17 MicroRNAs in Exhaled Breath Condensate and Bronchial Brushings as Biomarkers for Early Diagnosis of Lung Cancer

Journal of Thoracic Oncology

English

P2.15-30 Marital Status and Survival in Patients With Lung Cancer

Journal of Thoracic Oncology

English

P3.01-06 Concomitant Plasma-Genotyped T790M Positivity and Small Cell Carcinoma Transformation in EGFR-Mutated NSCLC

Journal of Thoracic Oncology

English

P1.02-03 the Role of Lung Cancer Advocacy Organizations in Biomarker Testing

Journal of Thoracic Oncology

English

P1.16-31 Surgically Resected Acinar Adenocarcinoma of the Lung: Analysis of Different Prognostic Groups

Journal of Thoracic Oncology

English

P2.03-30 Proteins Involved in Necroptosis and DNA Damage Repair and Survival of Stage I Non-Small-Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

P3.13-29 Patient-Derived Xenograft Models(PDX) of Lung Squamous Cell Carcinoma(SCC) for Preclinical Studies

Journal of Thoracic Oncology

English

P3.04-18 the Efficacy and Safety of Solid Tumors Combination Therapy With Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology

English

MA27.07 Lung Adenocarcinoma Harboring BRAF G469V Mutation Is Uniquely Sensitive to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology

English

119P Cisplatin/Etoposide or Paclitaxel/Carboplatin With Concurrent Radiation Therapy in Stage IIIB Non-Small Cell Lung Cancer: A One-Year Phase II Trial at a Low Resource Setting

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P2.11-17 MicroRNAs in Exhaled Breath Condensate and Bronchial Brushings as Biomarkers for Early Diagnosis of Lung Cancer

P2.15-30 Marital Status and Survival in Patients With Lung Cancer

P3.01-06 Concomitant Plasma-Genotyped T790M Positivity and Small Cell Carcinoma Transformation in EGFR-Mutated NSCLC

P1.02-03 the Role of Lung Cancer Advocacy Organizations in Biomarker Testing

P1.16-31 Surgically Resected Acinar Adenocarcinoma of the Lung: Analysis of Different Prognostic Groups

P2.03-30 Proteins Involved in Necroptosis and DNA Damage Repair and Survival of Stage I Non-Small-Cell Lung Cancer Patients

P3.13-29 Patient-Derived Xenograft Models(PDX) of Lung Squamous Cell Carcinoma(SCC) for Preclinical Studies

P3.04-18 the Efficacy and Safety of Solid Tumors Combination Therapy With Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis

MA27.07 Lung Adenocarcinoma Harboring BRAF G469V Mutation Is Uniquely Sensitive to EGFR Tyrosine Kinase Inhibitors

119P Cisplatin/Etoposide or Paclitaxel/Carboplatin With Concurrent Radiation Therapy in Stage IIIB Non-Small Cell Lung Cancer: A One-Year Phase II Trial at a Low Resource Setting